Fig. 3

Changes in peripapillary choroidal thickness (PCT) of the patient shown in Fig. 2. Peripapillary circle scans at baseline (a), 3 months (b) and 6 months after the intravitreal injection of ranibizumab (c). Nasal PCT at baseline (142 μm) was not changed at 3 months (146 μm) and 6 months (142 μm), while temporal PCT at baseline (133 μm) decreased at 3 months (121 μm) and 6 months (117 μm). T, temporal; S, superior; I, inferior; N, nasal